首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Role of NLRP3 Inflammasomes in Atherosclerosis
【24h】

Role of NLRP3 Inflammasomes in Atherosclerosis

机译:NLRP3炎性小体在动脉粥样硬化中的作用

获取原文
       

摘要

Inflammation with macrophage infiltration is a key feature of atherosclerosis. Although the mechanisms had been unclear, emerging evidence unveiled that NLRP3 inflammasomes, which regulate caspase-1 activation and subsequent processing of pro-IL-1β, trigger vascular wall inflammatory responses and lead to progression of atherosclerosis. NLRP3 inflammasomes are activated by various danger signals, such as cholesterol crystals, calcium phosphate crystals, and oxidized low-density lipoprotein in macrophages, to initiate inflammatory responses in the atherosclerotic lesion. Recent studies have further clarified the regulatory mechanisms and the potential therapeutic agents that target NLRP3 inflammasomes. In this study, we reviewed the present state of knowledge on the role of NLRP3 inflammasomes in the pathogenesis of atherosclerosis and discussed the therapeutic approaches that target NLRP3 inflammasomes.
机译:巨噬细胞浸润引起的炎症是动脉粥样硬化的关键特征。尽管其机制尚不清楚,但新的证据表明,NLRP3炎性小体调节caspase-1激活和随后的pro-IL-1β加工,触发血管壁炎症反应并导致动脉粥样硬化的发展。 NLRP3炎性小体被各种危险信号激活,例如巨噬细胞中的胆固醇晶体,磷酸钙晶体和氧化的低密度脂蛋白,从而引发动脉粥样硬化病变的炎症反应。最近的研究进一步阐明了靶向NLRP3炎性小体的调节机制和潜在的治疗剂。在这项研究中,我们回顾了有关NLRP3炎性小体在动脉粥样硬化发病机理中的作用的现有知识,并讨论了针对NLRP3炎性小体的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号